Clinical Pharmacokinetics of Neuromuscular Blocking Drugs
- 1 February 1992
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 22 (2) , 94-115
- https://doi.org/10.2165/00003088-199222020-00002
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Atracurium Decay and the Formation of Laudanosine in HumansAnesthesiology, 1991
- Pharmacokinetics and Neuromuscular Blocking Effects of Atracurium Besylate and Two of Its Metabolites in Patients with Normal and Impaired Renal FunctionClinical Pharmacokinetics, 1990
- Pharmacokinetics and Pharmacodynamics of Atracurium in the ElderlyAnesthesiology, 1990
- Reactivity and toxicity of atracurium and its metabolitesin vitroCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1989
- Atracurium, pharmacokinetics and metabolitesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1989
- Effect of Thermal Injury on the Pharmacokinetics and Pharmacodynamics of Atracurium in HumansAnesthesiology, 1989
- The Influence of Renal Failure on the Pharmacokinetics and Duration of Action of Pipecuronium Bromide in Patients Anesthetized with Halothane and Nitrous OxideAnesthesiology, 1989
- Quantitative estimation of quaternary ammonium neuromuscular blocking agents in serum by direct insertion probe chemical ionization mass spectrometryJournal of Mass Spectrometry, 1986
- Clinical Pharmacokinetics of the Non-depolarising Muscle RelaxantsClinical Pharmacokinetics, 1981
- Pancuronium and the placental barrierAnaesthesia, 1977